Clinical Trial Update: Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating fiducial markers to improve localization and accuracy of radiation therapy for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer, Cancer | Phase 1 | Status: COMPLETED